DE
46
3
HD
47
-5
MCO
73
3
MRK
22
3
HCP
58
4
AKAM
43
3
AZO
46
-3
DG
2
-6
VTR
49
-3
DVA
72
2
XEL
67
2
LLY
39
9
UHS
54
3
NWL
44
-4
MAS
51
4
ZBH
60
-2
RRC
63
3
HRL
39
15
HPE
55
11
ADP
64
2
DE
46
3
HD
47
-5
MCO
73
3
MRK
22
3
HCP
58
4
AKAM
43
3
AZO
46
-3
DG
2
-6
VTR
49
-3
DVA
72
2
XEL
67
2
LLY
39
9
UHS
54
3
NWL
44
-4
MAS
51
4
ZBH
60
-2
RRC
63
3
HRL
39
15
HPE
55
11
ADP
64
2
Financhill
Back

Biomarin Pharmaceutical Vs. Bristol-Myers Squibb Industry Stock Comparison

Buy
57

BMRN
Biomarin Pharmaceutical

Last Price:
63.63
Seasonality Move:
12.47%
Buy
53

BMY
Bristol-Myers Squibb

Last Price:
58.28
Seasonality Move:
2.73%
Buy
57
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $62.56. The Score for BMRN is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Bristol-Myers Squibb (BMY) is a Buy

Is Bristol-Myers Squibb a Buy, Sell or Hold?

  • The current Bristol-Myers Squibb [BMY] share price is $57.88. The Score for BMY is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • BMY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $62.56
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.

BMY Stock Price Chart

What is Bristol-Myers Squibb's stock price today?

  • The Bristol-Myers Squibb share price today is $57.88
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMY is experiencing selling pressure, which indicates risk of future bearish movement.

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.16 Sell
Relative Strength Index (14 RSI): 27.46 Sell
Chaikin Money Flow: 863717 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (64.41 - 69.77) Sell
Bollinger Bands (100): (68.48 - 87.38) Sell

BMY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.46 Buy
Relative Strength Index (14 RSI): 59.58 Buy
Chaikin Money Flow: -6758641 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.71 - 57.51) Buy
Bollinger Bands (100): (44.85 - 54.43) Buy

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.33 Sell
20-day SMA: 66.31 Sell
50-day SMA: 69.39 Sell
200-day SMA: 81.31 Sell
8-day EMA: 63.89 Sell
20-day EMA: 65.94 Sell
50-day EMA: 70.23 Sell
200-day EMA: 79.7 Sell

BMY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 58.11 Sell
20-day SMA: 55.66 Buy
50-day SMA: 53.17 Buy
200-day SMA: 48.42 Buy
8-day EMA: 57.39 Buy
20-day EMA: 56.06 Buy
50-day EMA: 53.58 Buy
200-day EMA: 50.65 Buy

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.83 per share.

Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.49 per share, and an increase next year of $6.16 per share.

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bristol-Myers Squibb Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):